Aarti Drugs Challenges GST Department's Demand of Rs. 230.70 Crores at Supreme Court

Aarti Drugs Ltd. has informed about a dispute with the GST Department, which has challenged an order by the Hon'ble High Court of Bombay at the Supreme Court. The dispute is about a Show Cause Notice for an alleged contravention of Rule 96(10) of CGST Rules, proposing to demand IGST of Rs. 230.70 Crores for FY 2017-18 to FY 2021-22. Aarti Drugs had filed a writ petition against the demand and penalty, which was allowed by the High Court. However, the GST Department has now filed a Special Leave Petition before the Supreme Court. The financial impact on the company is currently uncertain, and Aarti Drugs will take appropriate legal steps to defend its position.